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Metaplastic carcinoma with
extensive dendritic cell
differentiation: a previously
unrecognised type of
triple-negative breast cancer
We report on the case of a 48-year-old lady presenting
a nodule, 24 mm in diameter, in the right breast. A core biopsy
showed an undifferentiated tumour made of large cells in
syncitial arrangement, featuring vesicular irregularly shaped
nuclei with prominent nucleoli, and a high mitotic activity.
A huge number of inflammatory cells, particularly lymphocytes
and plasma cells, were intermingled with the neoplastic cells
(Figure 1A). Immunohistochemistry carried out by applying
antibodies raised against cytokeratin (CK) MNF-116, CK7, p63,
S100-protein, CD31, desmin, CD21, and CD35 showed a strong
and diffuse immunoreactivity for CD21 (Figure 1B) and CD35.
Based on the above morphological and immunophenotypical
findings, a diagnosis of dendritic cell sarcoma was rendered.
The patient received simple mastectomy without adjuvant
systemic therapy. The nodule showed the same histologic
features as the core biopsy. Immunostaining for CKs, CD21,
and CD35 was carried out in one of the five blocks obtained
from the tumour, the results being consistent with dendritic cell
sarcoma. Seven months after mastectomy, an enlarged
ipsilateral axillary lymph node was noted, and a complete
lymph node dissection was carried out. In one of the 18 lymph
nodes, a metastatic tumour was found, composed of cells
morphologically indistinguishable from those of the breast
neoplasia. At variance with the breast tumour, however, the
neoplastic cells in the lymph node were strongly
immunoreactive for CK7 and unreactive for the dendritic cell
markers CD21 and CD35. An extensive morphological and
immunohistochemical revision of all the breast tumour samples
yielded to pinpoint two foci of neoplastic cells strongly positive
for CK7. Noteworthy, one of these foci was composed of large
cells packed in cords, immunoreactive for CK7 only (Figure 1C),
whereas the other focus showed a few cells immunoreactive for
either CK7 or the dendritic cell marker CD21 (Figure 1D).
Clusterin resulted strongly positive in the dendritic cell
component also. Estrogen receptor, progesterone receptor and
Her-2/neu were negative in both primary tumour and metastasis.
These findings raised two hypotheses: a collision tumour
(dendritic cell sarcoma and poorly differentiated duct
carcinoma) or a metaplastic carcinoma showing
differentiation towards dendritic cell sarcoma. Given the
morphological and immunohistochemical findings, we
strongly favoured the second hypothesis. The patient was
treated with four cycles of adjuvant chemotherapy by using
the scheme FEC90 (5-fluorouracil, epirubicin, and
cyclophosphamide). She is alive and well 8 months after the
lymph node relapse.
Few cases of bona fide follicular dendritic cell sarcoma of the
breast have been described in the literature to date ([1] online,
[1–3]). Metaplastic carcinoma of the breast is an entity
Figure 1. Large neoplastic cells in syncitial arrangement with intermingled inflammatory component (A); immunohistochemical positivity for CD21 in
neoplastic cells (B); double immunostaining for CK7 (brown) and CD21 (red) highlights the two foci of carcinoma in the mammary tumour. One of the foci
expresses only the epithelial marker CK7 (C), while the other is composed of cells showing either epithelial or dendritic differentiation (D).
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encompassing many different histopathologic features, and
its classification includes two main subtypes: the purely
epithelial carcinoma, with the morphological variants of
squamous carcinoma, adenosquamous carcinoma, and
adenocarcinoma with spindle cell metaplasia, and the mixed
epithelial and mesenchymal tumours, i.e. carcinoma with
chondroid, osseous, and rhabdomyosarcomatous
differentiation, as well as carcinosarcoma [4]. Anectodic
cases of breast carcinomas showing unusual heterologous
components, such as melanocytic and neuroglial, have also
been reported, raising the question whether a multipotential
cell could play a role in this multilineage differentiation [5].
A correct distinction between metaplastic carcinoma and
dendritic cell sarcoma is far from being a merely nosologic
issue: mammary metaplastic carcinoma is usually associated
with a poor prognosis, and is almost invariably triple negative,
deserving therefore to be treated by intensive chemotherapy,
independent of the lymph node status ([2] online), while
dendritic cell sarcoma is considered an intermediate grade
malignancy ([3] online) that may be cured by surgery only,
especially if it does not involve regional lymph nodes [2].
In summary, the first case of a metaplastic carcinoma of the
breast showing extensive dendritic cell differentiation, herein
reported, expands the histopathologic spectrum of metaplastic
carcinoma and underlines the clinical usefulness of recognising
even small foci of epithelial differentiation in otherwise bona
fide mammary dendritic cell sarcoma.
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